ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Liudmila Castelo David, Teresa Mota Garcia, Isaulina Barreto, Esperança Carvalho, Laurinda Barreto, Clara Aleydis, Laurinda Coelho, Lúcio Lara Santos
Tsion Zebdiwos Chema, Edom Seife Woldetsadik, Girum Tessema Zingeta, Hawi Furgassa Bedada, Mohammed Ibrahim Adem, Jilcha Diribi Feyisa, Winini Belay, Mushonga Melinda, K S Han Kathy, Rebecca Wong, Munir Awol, Bargude Balta
Monika Sarade, Dipak Das, Sharyu Mhamane, Sandip Bhojane, Suvarna Patil, Shripad Banavali, Gagan Prakash, Atul Budukh
Juan Carlos Nuñez-Enriquez Daniela Medina-León, Diana Tinoco-Montejano, Karen Jacuinde-Trejo, Janet Flores-Lujano, Lissette Gómez-Rivera, Omar Chávez-Martínez, Francisco J García-Alvarado, Patricia Blanco-Padilla, Rosana Pelayo